In Vitro–In Vivo Correlation: Transdermal Drug Delivery Systems

2007 ◽  
pp. 153-176 ◽  
Author(s):  
Ayyappa Chaturvedula ◽  
Ajay K. Banga
Keyword(s):  
Drug Delivery ◽  
Transdermal Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Transdermal Drug Delivery Systems

scholarly journals Transdermal Drug Delivery Systems of a Beta Blocker: Design, In Vitro, and In Vivo Characterization

Drug Delivery ◽  
2004 ◽  
Vol 11 (1) ◽  
pp. 27-31 ◽  
Author(s):  
M. Aqil ◽  
Yasmin Sultana ◽  
Asgar Ali ◽  
Kiran Dubey ◽  
A. K. Najmi ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Beta Blocker ◽  
Transdermal Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Transdermal Drug Delivery Systems ◽  
In Vivo Characterization

Transdermal Drug Delivery Systems of Albuterol: In Vitro and In Vivo Studies

1992 ◽  
Vol 81 (10) ◽  
pp. 996-999 ◽  
Author(s):  
Rajeev Gokhale ◽  
Cynthia Schmidt ◽  
Lisa Alcorn ◽  
James Stolzenbach ◽  
Grant Schoenhard ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Transdermal Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
In Vivo Studies ◽  
Transdermal Drug Delivery Systems

scholarly journals STAR particles in context: a novel contender in the search for optimized drug-delivery systems

2021 ◽  
Author(s):  
Faris Soloman Almadi ◽  
Saad I Mallah
Keyword(s):  
Drug Delivery ◽  
Targeted Delivery ◽  
Drug Delivery Systems ◽  
Topical Therapy ◽  
Delivery Systems ◽  
Minimal Invasiveness ◽  
Transdermal Drug Delivery Systems ◽  
User Friendly

Targeted delivery, maximized bioavailability, minimal invasiveness, minimal side effects and cost–effectiveness are all markers of a successful drug delivery method. Although topical therapy, where diseased skin is targeted, remains a method of limited use, transdermal drug delivery systems seek to utilize skin as a vehicle for deeper systemic effects. Recently, Tadros et al. outlined an innovation to maximize the potential of topical delivery as a minimally invasive, user-friendly and safe medium. STAR particles seek to improve transdermal delivery by creating micropores in the stratum corneum. Several investigations have been conducted with promising results, including in vitro and in vivo animal and human studies. Despite a number of limitations and further considerations, the potential implications of STAR particles in the clinical disease setting are monumental.

Sign in / Sign up

Export Citation Format

Share Document